Vienna, Austria

Corinna Kern


 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Corinna Kern: Innovator in Toxin-Cleaving Polypeptide Variants

Introduction

Corinna Kern is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptide variants that can cleave fusarium toxins. Her innovative work has the potential to impact various industries, including agriculture and food safety.

Latest Patents

Corinna Kern holds a patent for "Fusarium toxin-cleaving polypeptide variants, additive containing same, use of same, and method for splitting fusarium toxins." This invention relates to toxin-cleaving polypeptide variants of a toxin carboxyl esterase with the SEQ ID NO:46. Each of the polypeptide variants has an amino acid sequence shortened by 47 amino acids at the N terminus, and the amino acid sequences have at least 70%, preferably 80%, and in particular 100%, sequence identity to the amino acid sequence portion 48-540 of the SEQ ID NO:46. The invention also includes isolated polynucleotides that code for the polypeptide variants, an additive containing at least one polypeptide variant, and a method for hydrolytically cleaving at least one toxin.

Career Highlights

Corinna Kern is associated with Erber Aktiengesellschaft, a company known for its focus on innovative solutions in the agricultural sector. Her work at the company has allowed her to explore and develop groundbreaking technologies that address critical challenges in toxin management.

Collaborations

Throughout her career, Corinna has collaborated with notable colleagues, including Markus Aleschko and Dieter Moll. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their projects.

Conclusion

Corinna Kern's contributions to the field of biotechnology, particularly through her patent on toxin-cleaving polypeptide variants, highlight her role as an influential inventor. Her work continues to pave the way for advancements in toxin management and safety in various applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…